Abnova/COVID-19病毒抗原快速检测（CE-IVD）/1kit/DC0302
市场价：
¥0.00
美元价：
0.00
联系Q Q：
3392242852
电话号码：
4000-520-616
电子邮箱：
info@ebiomall.com
商品介绍
- Specification
- Product Description:
- COVID-19 Viral Antigen Rapid Test provides a fast, convenient, and qualitative testing of SARS nucleocapsid antigens from nasal swabs in individuals who are suspected of COVID-19 (SARS-CoV-2) within first 12 days of symptom onset.
- Supplied Product:
- 25 Test Kit:COVID-19 Antigen Testing Strips (25) - Colloidal gold-labeled COVID-19 nucleocapsid murine monoclonal antibody - COVID-19 nucleocapsid human monoclonal antibody - Goat anti-murine polyclonal antibody Extraction Buffers (25) - Extraction reagentDroppers (25) - 100 uL Dropper for drawing sample mixturePositive Control Swab (1) - Non-infectious, recombinant viral nucleocapsid protein with less than 0.1% sodium azideNegative Control Swab (1) - Buffer with less than 0.1% sodium azideAssay Documentation (1) - Instructions for Use
- Storage Instruction:
- Store product at 15°C-30°C (59°F-86°F) and avoid direct exposure to sunlight.Do not freeze or store the product outside the temperature range described above.Do not open until ready to use.Do not use it after the expiration date.
- Note:
- Product Image
Fresh Specimen Sampling Procedure and Test
- Suitable Sample:
- Nasal Swab Specimen
- Features:
- Fast result in 15 minutesEasy to operateHighly sensitive via visual inspection
- Material RequiredBut Not Provided:
- Nasal specimen sampling swabs - FLOQSwabs®, Cat# 519C501, COPAN ITALIA SpA - Swabs, Cat# 0410, Labospace ITALIATube rack for specimensTimer or watchPersonal protective equipments
- Intended Use:
- This product is a chromatographic immunoassay for the rapid and qualitative detection of SARS nucleocapsid antigens from nasal swabs in individuals who are suspected of COVID-19 within first 12 days of symptom onset.
- Regulatory Status:
- GMP gradeCE-IVD approved
- Adverse Events:
- Reporting adverse events
- InstructionsFor Use:
Instructions For Use (English)Instructions For Use (German)Instructions For Use (Japanese)
- Flyer:
- Download flyer
- Datasheet:
- Download
- Video:
- Applications
- Lateral Flow Immunoassay
- Result Zone of the COVID-19 Antigen Testing Strip indicates Test line (T line) Control line (C line). C line must appear to ensure the quality of sample processing.Note: Report all positive results to the appropriate public health authorities. For invalid results, review the procedure and repeat the procedure with a new test. If the problem persists, discontinue using the test kit and contact local distributors and Abnova.
- Lateral Flow Immunoassay
- PPA: 100% (C.I. 84%-100%) NPA: 95% (C.I. 87%-98%) OPA: 96% (C.I. 90%-99%)81 direct nasal swabs were prospectively collected and enrolled from individual symptomatic patients (within12 days of onset) who were suspected of COVID-19. The performance of the Abnova COVID-19 Viral Antigen Rapid Test wascomparedtoresults of a nasopharyngeal swab testedwith an Emergency Use Authorized molecular (RT-PCR) test for detection of SARS-CoV-2.
- Application Image
- Lateral Flow Immunoassay
- enlarge
- Lateral Flow Immunoassay
- enlarge
品牌介绍
Abnova是世界上最大的抗体制造商。亚诺法的所有产品，重组蛋白和抗体都是利用最新的技术及由SPF等级动物实验室制造生产出来。我们的目标是生产人类基因组内每个基因至少要有一个相对应的抗体，可以提供给来自于学术机构、行业的伙伴和合作者做研究。亚诺法有许多多样化的单克隆及多克隆抗体，我们更进一步开发一系列的整合系统与相关应用包含配对抗体、ELISA试剂盒与荧光原位杂交(FISH)探针。这些工具对生物标记开发与转译研究都是必须的。亚诺法亦有针对糖尿病、传染疾病与癌症的体外检验试剂专案以及用于治疗败血症的全人类抗体药技专案，为全人类的健康努力。
联络我们
